Anna Villar-Pique
Overview
Explore the profile of Anna Villar-Pique including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herden J, Hermann P, Schmidt I, Dittmar K, Canaslan S, Weglage L, et al.
Alzheimers Res Ther
. 2023 Jun;
15(1):116.
PMID: 37349779
No abstract available.
2.
Herden J, Hermann P, Schmidt I, Dittmar K, Canaslan S, Weglage L, et al.
Alzheimers Res Ther
. 2023 Jun;
15(1):106.
PMID: 37291640
Background: Rapidly progressive forms of Alzheimer's disease (rpAD) are increasingly recognized and may have a prevalence of up to 30% of patients among all patients with Alzheimer's disease (AD). However,...
3.
Schmitz M, Canaslan S, Espinosa J, Fernandez-Borges N, Villar-Pique A, Llorens F, et al.
Mol Neurobiol
. 2022 Jun;
59(9):1-9.
PMID: 35716271
Biomarkers are becoming increasingly important for the differential diagnosis of neurodegenerative diseases. Previous observations indicated neurofilament light chain (NfL) as a potential blood-based biomarker for sporadic Creutzfeldt-Jakob disease (sCJD). Here,...
4.
Schmitz M, Villar-Pique A, Hermann P, Escaramis G, Calero M, Chen C, et al.
Brain
. 2022 Mar;
145(2):700-712.
PMID: 35288744
Genetic prion diseases are a rare and diverse group of fatal neurodegenerative disorders caused by pathogenic sequence variations in the prion protein gene, PRNP. Data on CSF biomarkers in patients...
5.
Hermann P, Canaslan S, Villar-Pique A, Bunck T, Goebel S, Llorens F, et al.
Eur J Neurol
. 2022 Feb;
29(6):1841-1846.
PMID: 35212083
Background And Purpose: Fatal familial insomnia is a rare hereditary prion disease associated with the D178N-129M PRNP mutation. Early diagnosis is difficult, because the clinical syndrome may overlap with affective...
6.
Hermann P, Villar-Pique A, Schmitz M, Schmidt C, Varges D, Goebel S, et al.
Alzheimers Res Ther
. 2022 Jan;
14(1):9.
PMID: 35027079
Background: Lipocalin-2 is a glycoprotein that is involved in various physiological and pathophysiological processes. In the brain, it is expressed in response to vascular and other brain injury, as well...
7.
Canaslan S, Schmitz M, Villar-Pique A, Maass F, Gmitterova K, Varges D, et al.
Front Aging Neurosci
. 2021 Oct;
13:717930.
PMID: 34630068
Alpha-synucleinopathies, such as Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), are a class of neurodegenerative diseases. A diagnosis may be challenging because clinical symptoms...
8.
Schmitz M, Canaslan S, Villar-Pique A, Gmitterova K, Varges D, Lingor P, et al.
Mov Disord
. 2021 Aug;
36(11):2701-2703.
PMID: 34379333
No abstract available.
9.
Espin R, Baiges A, Blommaert E, Herranz C, Roman A, Saez B, et al.
Mol Cancer Res
. 2021 Jul;
19(11):1840-1853.
PMID: 34312290
Lymphangioleiomyomatosis (LAM) is a rare, low-grade metastasizing disease characterized by cystic lung destruction. LAM can exhibit extensive heterogeneity at the molecular, cellular, and tissue levels. However, the molecular similarities and...
10.
Zerr I, Villar-Pique A, Hermann P, Schmitz M, Varges D, Ferrer I, et al.
Alzheimers Res Ther
. 2021 Apr;
13(1):86.
PMID: 33883011
Background: Blood neurofilament light (Nfl) and total-tau (t-tau) have been described to be increased in several neurological conditions, including prion diseases and other neurodegenerative dementias. Here, we aim to determine...